To screen ETFs by asset class, performance, yield and more, check out the
View as an RSS Feed
) plans to spin off its remaining stake in Zoetis (
) through a tax-free exchange offer in which Pfizer owners can exchange their Pfizer shares for stock in Zoetis owned by Pfizer (got that?). Pfizer has received a waiver of the 180-day lock-up from the book runners of the Zoetis IPO. PFE
View news story
This transaction is a split off which is basically an exchange of Pfizer shares for Zoetis shares.
Besides having the tax free benefits similar to a spin off - in this case Pfizer preserved their optionality on the carve out IPO by retaining more than 80% of the voting control - it is a great way to create a "buy back" for Pfizer shares and thus reduce Pfizer shares outstanding.
Since the Zoetis stock has done so well, the company probably chose to use this split off vs a simple spin off. Split offs are usually done when the initial IPO stock has done well. The stock came out at $26 and has traded as high as $35 area.
So Pfizer gets two benefits from this transaction, tax free proceeds AND a reduction in Pfizer shares outstanding.
May 22 01:40 PM
Link to Comment
Xignite quote data
© 2014 Seeking Alpha